Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma

SIMPLE SUMMARY: Around 30–40% of patients with diffuse large B cell lymphoma suffer early relapse after standard chemotherapy, but today no prediction whether a patient belongs to this group is possible. MicroRNA are small nucleotide sequences that regulate cellular functions via post-transcriptiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Bento, Leyre, Vögler, Oliver, Sas-Barbeito, Adriana, Muncunill, Josep, Ros, Teresa, Martínez, Jordi, Quintero-Duarte, Adriana, Ramos, Rafael, Asensio, Víctor Jose, Fernández-Rodríguez, Concepción, Salar, Antonio, Navarro, Alfons, del Campo, Raquel, Ibarra, Javier, Alemany, Regina, Gutiérrez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870558/
https://www.ncbi.nlm.nih.gov/pubmed/35205813
http://dx.doi.org/10.3390/cancers14041065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870558/
https://www.ncbi.nlm.nih.gov/pubmed/35205813
http://dx.doi.org/10.3390/cancers14041065

Ejemplares similares